131 related articles for article (PubMed ID: 3521784)
21. Adjuvant therapy in colorectal cancer. (A randomized trial comparing radio-chemotherapy and radio-chemotherapy combined with the methanol extraction residue of BCG, MER).
Robinson E; Bartal A; Cohen Y; Milstein D; Mekori T
Biomedicine; 1979 Feb; 31(1):8-10. PubMed ID: 383171
[TBL] [Abstract][Full Text] [Related]
22. Phase I-II evaluation of razoxane (ICRF-159) and doxorubicin in gastrointestinal cancer. A Southeastern Cancer Study Group Trial.
DeSimone PA; Greco FA; Omura GA; Bartolucci A
Am J Clin Oncol; 1986 Jun; 9(3):185-6. PubMed ID: 3728369
[TBL] [Abstract][Full Text] [Related]
23. Trials of adjuvant chemotherapy in colorectal cancer.
Gilbert JM
Drugs Exp Clin Res; 1986; 12(1-3):201-10. PubMed ID: 3525074
[TBL] [Abstract][Full Text] [Related]
24. Effect of adjuvant chemo- or immunotherapy on the prognosis of colorectal cancer operated for cure.
Wunderlich M; Schiessel R; Rainer H; Rauhs R; Kovats E; Schemper M; Dittrich C; Micksche M; Sedlacek HH
Br J Surg; 1985 Sep; 72 Suppl():S107-10. PubMed ID: 3899250
[TBL] [Abstract][Full Text] [Related]
25. [Radio-oncological treatment possibilities in local recurrence of rectal carcinoma. An interdisciplinary comparison].
Rhomberg W; Eiter H
Wien Med Wochenschr; 1990 Apr; 140(8):206-11. PubMed ID: 2194376
[TBL] [Abstract][Full Text] [Related]
26. Five-year results of a randomized controlled trial of adjuvant chemotherapy for curatively resected colorectal carcinoma. The Colorectal Cancer Chemotherapy Study Group of Japan.
Jpn J Clin Oncol; 1995 Jun; 25(3):91-103. PubMed ID: 7596054
[TBL] [Abstract][Full Text] [Related]
27. Comparison of radiotherapy with and without razoxane (ICRF 159) in the treatment of soft tissue sarcomas.
Hellmann K; Ryall RD; Macdonald E; Newton KA; James SE; Jones S
Cancer; 1978 Jan; 41(1):100-7. PubMed ID: 414829
[TBL] [Abstract][Full Text] [Related]
28. Randomized phase II studies in advanced colorectal carcinoma: a North Central Cancer Treatment Group study.
Windschitl H; Scott M; Schutt A; McCormack G; Everson L; Cullinan S; Gerstner J; Krook J; Laurie J; Shreck R
Cancer Treat Rep; 1983 Nov; 67(11):1001-8. PubMed ID: 6640551
[TBL] [Abstract][Full Text] [Related]
29. Long-term results of single course of adjuvant intraportal chemotherapy for colorectal cancer. Swiss Group for Clinical Cancer Research (SAKK).
Lancet; 1995 Feb; 345(8946):349-53. PubMed ID: 7845115
[TBL] [Abstract][Full Text] [Related]
30. A trial of razoxane (ICRF-159) in patients with prior therapy for Hodgkin's lymphoma.
Corder MP; McFadden DB; Bell SJ
Cancer; 1984 Oct; 54(8):1496-8. PubMed ID: 6383594
[TBL] [Abstract][Full Text] [Related]
31. Adjuvant therapy for colorectal carcinoma.
Kim R; Yamaguchi Y; Toge T
Anticancer Res; 2002; 22(4):2413-8. PubMed ID: 12174936
[TBL] [Abstract][Full Text] [Related]
32. [Studies on the effects of adjuvant chemotherapy on the survival period of patients with colorectal carcinoma].
Jo T
Nihon Geka Gakkai Zasshi; 1985 Jun; 86(6):697-708. PubMed ID: 3929067
[TBL] [Abstract][Full Text] [Related]
33. [Adjuvant chemotherapy of colorectal cancer--results of prospective randomized trials].
Hojo K; Kajitani T
Gan To Kagaku Ryoho; 1986 Oct; 13(10):3063-73. PubMed ID: 3094459
[TBL] [Abstract][Full Text] [Related]
34. Immunohistochemical evaluation of thymidylate synthase (TS) and p16INK4a in advanced colorectal cancer: implication of TS expression in 5-FU-based adjuvant chemotherapy.
Kamoshida S; Matsuoka H; Ishikawa T; Maeda K; Shimomura R; Inada K; Tsutsumi Y
Jpn J Clin Oncol; 2004 Oct; 34(10):594-601. PubMed ID: 15591457
[TBL] [Abstract][Full Text] [Related]
35. Phase II study of dianhydrogalactitol and ICRF-159 in patients with advanced breast cancer previously exposed to cytotoxic chemotherapy.
Ahmann DL; O'Connell MJ; Bisel HF; Edmonson JH; Hahn RG; Frytak S
Cancer Treat Rep; 1977; 61(1):81-2. PubMed ID: 324622
[No Abstract] [Full Text] [Related]
36. A randomized controlled trial of adjuvant portal vein cytotoxic perfusion in colorectal cancer.
Taylor I; Machin D; Mullee M; Trotter G; Cooke T; West C
Br J Surg; 1985 May; 72(5):359-63. PubMed ID: 3888335
[TBL] [Abstract][Full Text] [Related]
37. Combination chemotherapy in patients with advanced colorectal carcinoma previously treated with 5-FU.
Windschitl HE; Krook JE; Everson LK; Cullinan SA; Scott M
Cancer Treat Rep; 1982 Dec; 66(12):2093-4. PubMed ID: 7139652
[No Abstract] [Full Text] [Related]
38. Adjuvant treatment with razoxane (ICRF 159) following resection of cancer of the stomach.
Gilbert JM; Cassell P; Ellis H; Wastell C; Hermon-Taylor J; Hellman K
Recent Results Cancer Res; 1978; 68():217-21. PubMed ID: 752859
[No Abstract] [Full Text] [Related]
39. Fluorouracil in chemoprophylaxis of colorectal cancer. Results of a controlled clinical trial.
Irvin T; Vowles KD; Golby MG
Dis Colon Rectum; 1986 Nov; 29(11):704-6. PubMed ID: 3533469
[TBL] [Abstract][Full Text] [Related]
40. Antimetastatic effects of razoxane in a rat osteosarcoma model.
Wingen F; Spring H; Schmähl D
Clin Exp Metastasis; 1987; 5(1):9-16. PubMed ID: 3470164
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
